Michael G Cedars, MD
Plastic and Reconstructive Surgery · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 49 years
- University of California, San Francisco School of Medicine, 1977
Offices
1 location
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cedars’s office at (510) 763-2662 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G38306 · Current
Licensed to practise in California · since 1978 · expires 2028-07-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$12,081
Medicare paid this office $12,081 for 37 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 22 | $2,147 | $98 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
37 Original Medicare patients in 2024. Average age 76 · Women 65% · Health risk score 0.87. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: High blood pressure 46%.
The office billed $27,816, Medicare allowed $15,393 and paid $12,081; for 81 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 37 | 81 | 76 | 0.87 | $27,816 | $12,081 |
| 2023 | 32 | 68 | 76 | 1.14 | $25,461 | $10,788 |
| 2022 | 29 | 64 | 75 | 0.93 | $17,493 | $8,479 |
| 2021 | 32 | 77 | 73 | 0.64 | $31,556 | $12,718 |
| 2020 | 28 | 60 | 74 | 1.03 | $21,090 | $8,759 |
| 2019 | 23 | 50 | 74 | 0.74 | $17,316 | $8,133 |
| 2018 | 27 | 46 | 73 | 0.72 | $16,600 | $7,394 |
| 2017 | 37 | 77 | 73 | 0.83 | $41,610 | $12,519 |
| 2016 | 33 | 63 | 73 | 0.68 | $30,260 | $10,332 |
| 2015 | 41 | 87 | 74 | 0.90 | $38,887 | $13,844 |
| 2014 | 43 | 107 | 73 | 0.82 | $47,503 | $17,823 |
| 2013 | 33 | 71 | 73 | 1.01 | $22,753 | $10,801 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| New patient visit (30+ min) | 14 | $1,396 | $100 |
2022: 1 service
| New patient visit (30+ min) | 18 | $1,783 | $99 |
2021: 1 service
| New patient visit (30+ min) | 12 | $1,209 | $101 |
2020: 1 service
| New patient visit (30+ min) | 12 | $1,120 | $93 |
2018: 1 service
| New patient visit (30+ min) | 13 | $1,125 | $87 |
2017: 1 service
| New patient visit (30+ min) | 15 | $1,077 | $72 |
2016: 1 service
| New patient visit (30+ min) | 11 | $896 | $81 |
2015: 2 services
| New patient visit (30+ min) | 13 | $1,176 | $90 |
| Short return visit (20+ min) | 13 | $879 | $63 |
2014: 1 service
| Short return visit (20+ min) | 23 | $1,875 | $62 |
Medicaid work
$443 in 2023
Medicaid paid $443 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 13 | $443 |
| 2023 | 13 | 1 | 13 | $443 |
| 2022 | 37 | 1 | 22 | $1,262 |
| 2021 | 123 | 1 | 21 | $4,194 |
| 2020 | 17 | 1 | 17 | $580 |
| 2019 | 328 | 1 | 31 | $11,168 |
| 2018 | 275 | 2 | 36 | $10,209 |
See the largest Medicaid services in earlier years
2022
| Service | 37 | $1,262 |
2021
| Service | 123 | $4,194 |
2020
| Service | 17 | $580 |
2019
| Service | 328 | $11,168 |
2018
| Service | 261 | $8,883 |
| Service | 14 | $1,326 |
Drugs they prescribed that Part D paid
$722
Pharmacies billed $722 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 45% of their Part D prescriptions (36 of 80) in 2024. Above the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 28%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
74 generic and fewer than 11 brand-name prescriptions · $722 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 23 | $85 | $3 |
Year by year
| 2024 | 80 | 35 | 45% (36) | None | $722 |
| 2023 | 61 | 26 | 33% (20) | None | $774 |
| 2022 | 57 | 21 | 39% (22) | None | $690 |
| 2021 | 39 | 23 | 54% (21) | None | $375 |
| 2020 | 32 | 17 | 47% (15) | 0% | $267 |
| 2019 | 35 | 18 | 43% (15) | None | $366 |
| 2018 | 35 | 19 | 34% (12) | None | $513 |
| 2017 | 39 | 23 | 51% (20) | None | $515 |
| 2016 | 24 | 15 | None | None | $994 |
| 2015 | 48 | 26 | 44% (21) | None | $983 |
| 2014 | 21 | 12 | 62% (13) | None | $155 |
| 2013 | 20 | 11 | None | None | $333 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Hydrocodone-Acetaminophen | 18 | $85 | $5 |
| Ondansetron Odt | 13 | $25 | $2 |
2022: 1 drug
| Hydrocodone-Acetaminophen | 20 | $89 | $4 |
2021: 1 drug
| Hydrocodone-Acetaminophen | 21 | $93 | $4 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 13 | $60 | $5 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 12 | $71 | $6 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 11 | $70 | $6 |
Money from drug and device companies
$37 in 2025
| 2025 | 2 | 2 | None | $37 |
| 2024 | 3 | 6 | None | $319 |
| 2023 | 1 | 1 | None | $17 |
| 2022 | 1 | 1 | None | $16 |
| 2019 | 2 | 7 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $19 | 1 payment
|
| KLS-Martin L.P. | None | $18 | 1 payment
|
See all 2 published payments
| KLS-Martin L.P. | Meals · 2025-10-11 | None | $18 |
| Vertex Pharmaceuticals | Meals · 2025-09-16 | Journavx | $19 |
See earlier years (2024, 2023, 2022, 2019)
2024: $319
| Revance Therapeutics | Daxxify | $260 | 3 payments
|
| Abbvie | Botox | $30 | 2 payments
|
| Merz North America | None | $29 | 1 payment
|
2023: $17
| AbbVie | Botox | $17 | 1 payment
|
2022: $16
| Allergan | Botox | $16 | 1 payment
|
2019: $87
| Allergan | Botox Cosmetic | $57 | 5 payments
|
| Galderma Laboratories L.P. | None | $30 | 2 payments
|
Professional record
- NPI
- 1205821402
- Licence
- CA G38306California G38306: Current · expires 2028-07-31
- Trained
- University of California, San Francisco School of Medicine, 1977 · 49 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G383060
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- 3300 Webster St, Oakland, CA, 94609
- NPI first listed
- 2005-09-13
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.